Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other financing activities (2016 - 2025)

Historic Other financing activities for Amphastar Pharmaceuticals (AMPH) over the last 9 years, with Q3 2025 value amounting to $4000.0.

  • Amphastar Pharmaceuticals' Other financing activities fell 9931.86% to $4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $657000.0, marking a year-over-year decrease of 5052.71%. This contributed to the annual value of $816000.0 for FY2024, which is 9674.63% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Other financing activities is $4000.0, which was down 9931.86% from $253000.0 recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other financing activities peaked at $10.4 million during Q3 2023, and registered a low of -$22000.0 during Q4 2024.
  • In the last 5 years, Amphastar Pharmaceuticals' Other financing activities had a median value of $252500.0 in 2024 and averaged $938500.0.
  • In the last 5 years, Amphastar Pharmaceuticals' Other financing activities plummeted by 10448.98% in 2024 and then skyrocketed by 2540000.0% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other financing activities (Quarter) stood at $308000.0 in 2021, then plummeted by 99.03% to $3000.0 in 2022, then skyrocketed by 16233.33% to $490000.0 in 2023, then plummeted by 104.49% to -$22000.0 in 2024, then skyrocketed by 118.18% to $4000.0 in 2025.
  • Its Other financing activities was $4000.0 in Q3 2025, compared to $253000.0 in Q2 2025 and $422000.0 in Q1 2025.